Daniel M Halperin

11PUBLICATIONS
95CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cross-sectional analysisDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 10, 2025
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors.

Reed I Ayabe, Y David Seo, Brenda Melendez

|Feb 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Suyu Liu, Kangyu Lin

|Oct 25, 2024
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study.

Qing H Meng, Thorvardur R Halfdanarson, Joshua A Bornhorst

|May 06, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

Nicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes

|Feb 08, 2024
Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy.

Igryl S Cordero-Hernandez, Alicia C Ross, Arvind Dasari

|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.

Apostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson

Pageof 2

Frequent Collaborators

4 joint publications

Mark Knafl

3 joint publications

Suyu Liu

3 joint publications

Scott Woodman

2 joint publications

Michael J Overman